Back to search
Sarcoidosis, Pulmonary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sarcoidosis, Pulmonary trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Sarcoidosis, Pulmonary trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (P…
This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examinin…
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data…
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
This study aims to characterize the epidemiology of interstitial lung diseases (ILD) associated to connective tissue disease (CTD) in Mexico, and to study its c…
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), combined with endobronchial biopsy (EBB) and/or transbronchial lung biopsy (TBLB),…
Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary In…